When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.
Be alerted of any news about your stocks and see what other stocks are trending.
KPTI - FDA accepts Karyopharm application for expanded use of selinexor
Karyopharm Therapeutics Inc.
Under Priority Review status, the FDA accepts Karyopharm Therapeutics' (NASDAQ:KPTI) supplemental marketing application seeking approval to use Xpovio (selinexor) to treat adults with relapsed/refractory diffuse large B-cell lymphoma who have received at least two prior therapies.
More news on: Karyopharm Therapeutics Inc., Healthcare stocks news, Stocks on the move,